Related Experiment Video
Updated: Jan 19, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Severe Group A and Group B Streptococcus Diseases at a Pediatric ICU: Are they Still Sensitive to the Penicillins?
Kam L Hon1, Tai C Chow1, Tsun S Cheung1
1Faculty of Medicine, The Chinese University of Hong Kong, Central Ave, Hong Kong.
Insights
Severe Group A and B Streptococcus infections in children are rare but deadly, requiring intensive care. Prompt antibiotic treatment and supportive care are crucial for survival in Pediatric Intensive Care Units (PICU).
Area of Science:
- Pediatric Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Group A Streptococcus (GAS) and Group B Streptococcus (GBS) are significant pediatric pathogens.
- Severe infections, though uncommon, carry high mortality and morbidity, often needing intensive care.
Purpose of the Study:
- To review the mortality and morbidity associated with severe GAS and GBS infections in a Pediatric Intensive Care Unit (PICU).
Main Methods:
- Retrospective analysis of children admitted to a PICU between October 2002 and May 2018.
- Inclusion criteria: laboratory-proven GAS and GBS isolations.
Main Results:
- 19 patients (0.7% PICU admissions) identified with GAS (n=11) or GBS (n=8).
- GBS affected younger infants; cerebrospinal fluid was more often positive in GBS cases.
- Nearly 40% mortality observed, with high rates of mechanical ventilation and inotropic support.
Conclusions:
- Severe GAS and GBS infections pose significant risks in the PICU, despite rarity.
- Penicillin remains effective; prompt recognition and treatment are vital.
- High PIM2 and Sepsis scores indicate the need for timely intensive care interventions.
Background:
Group A β-hemolytic Streptococcus (GAS) and Group B streptococcus (GBS) are two common pathogens that are associated with many diseases in children. Severe infections as a result of these two streptococci are albeit uncommon but associated with high mortality and morbidity, and often necessitate intensive care support. This paper aims to review the mortality and morbidity of severe infection associated with GAS and GBS isolations at a Pediatric Intensive Care Unit (PICU).
Methods:
All children admitted to PICU of a teaching hospital between October 2002 and May 2018 with laboratory-proven GAS and GBS isolations were included.
Results:
There were 19 patients (0.7% PICU admissions) with streptococcal isolations (GAS, n=11 and GBS, n=8). Comparing to GAS, GBS affected infants were younger (median age 0.13 versus 5.47 years, 95% CI, 1.7-8.5, p=0.0003), and cerebrospinal fluids more likely positive (p = 0.0181). All GAS and GBS were sensitive to penicillin (CLSI: MICs 0.06 - 2.0 μg/mL), with the majority of GAS sensitive to clindamycin and erythromycin, and half of the GBS resistant to clindamycin and erythromycin. Co-infections were prevalent, but viruses were only isolated with GAS (p=0.024). Isolation of GAS and GBS was associated with nearly 40% mortality and high rates of mechanical ventilation and inotropic supports. All non-survivors had high mortality (PIM2) and sepsis scores.
Conclusions:
Severe GAS and GBS are rare but associated with high mortality and rates of mechanical ventilation and inotropic supports in PICU. The streptococci are invariably sensitive to penicillin. The high PIM2 and Sepsis scores suggest that prompt recognition of sepsis and the timely judicious institution of antibiotics and intensive care support may be life-saving for these devastating infections.
More Related Videos
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption